Medifast, Inc. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent
Medifast, Inc. (MED) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent of 0.60% for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-16.
Discontinued › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment · last filed 2017-03-16
- Medifast, Inc. effective income tax rate reconciliation, nondeductible expense, research and development, percent for fiscal 2016 was 0.60%, a 25.00% decline from fiscal 2015.
- Medifast, Inc. effective income tax rate reconciliation, nondeductible expense, research and development, percent for fiscal 2015 was 0.80%, a 33.33% increase from fiscal 2014.
- Medifast, Inc. effective income tax rate reconciliation, nondeductible expense, research and development, percent for fiscal 2014 was 0.60%.
- Medifast, Inc. effective income tax rate reconciliation, nondeductible expense, research and development, percent for fiscal 2013 was -1.20%.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent 12 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent 12 month as first filed |
|---|---|---|
| 2016-12-31 | 0.60% 10-K · filed 2017-03-16 | |
| 2015-12-31 | 0.80% 10-K · filed 2017-03-16 | -0.80% 10-K · filed 2016-03-15 |
| 2014-12-31 | 0.60% 10-K · filed 2017-03-16 | -0.60% 10-K · filed 2015-03-16 |
| 2013-12-31 | -1.20% 10-K · filed 2016-03-15 | -1.30% 10-K · filed 2014-03-17 |
| 2012-12-31 | -0.90% 10-K · filed 2015-03-16 | -1.10% 10-K · filed 2013-03-15 |
| 2011-12-31 | -1.20% 10-K · filed 2014-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COFFEE HOLDING CO INC (JVA) | United States | $0.023B | 4.10 |